• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多领域患者报告结局测量在多发性硬化症中检测临床疾病进展的应用。

The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.

机构信息

Dept. of Neurology, Haaglanden Medisch Centrum, Den Haag, Netherlands; Dept. of Neurology, Amsterdam UMC, location VUmc. Amsterdam, Netherlands.

Dept. of Neurology, Amsterdam UMC, location VUmc. Amsterdam, Netherlands.

出版信息

Mult Scler Relat Disord. 2021 Oct;55:103165. doi: 10.1016/j.msard.2021.103165. Epub 2021 Jul 29.

DOI:10.1016/j.msard.2021.103165
PMID:34404022
Abstract

OBJECTIVE

Patient reported outcome measures (PROMs) are especially relevant in times of increased interest in telehealth but little is known about their relation to functional disability measures.

METHODS

We assessed 248 people with MS at baseline and at > = 5-years follow-up. We investigated cross-sectional and longitudinal correlations between changes in the Guy's Neurological disability scale (GNDS), and the physical part of the Multiple Sclerosis Impact Scale (MSIS-29) and the Expanded Disability Status Scale (EDSS), 9-hole peg test (9-HPT) and timed 25-foot walk (T25FW).

RESULTS

The strongest cross-sectional correlations were found between the GNDS and EDSS in the complete cohort (r = 0.66, p <.001, n = 248) as well as in progressive patients (r = 0.72, p <.001, n = 35), and the GNDS and T25FW in progressive MS (r = 0.64, p <.001, n = 34). Longitudinal correlations were poor except for changes on the leg domain of the GNDS in relation to T25FW changes in progressive MS (r = 0.68, p <.001, n = 26). In the majority of cases a clinically significant deterioration on the EDSS also resulted in a clinically significant worsening of the GDNS and MSIS.

CONCLUSION

Both PROMs correlate well with physical disability outcomes, and seem suitable for detecting changes in lower limb function in progressive MS. The GNDS has a higher agreement with EDSS progression than the MSIS-physical.

摘要

目的

患者报告的结果测量(PROM)在对远程医疗兴趣增加的时代特别相关,但对其与功能残疾测量的关系知之甚少。

方法

我们在基线和随访> = 5 年时评估了 248 名 MS 患者。我们调查了 Guy 的神经功能障碍量表(GNDS)、多发性硬化症影响量表(MSIS-29)和扩展残疾状态量表(EDSS)、9 孔钉测试(9-HPT)和定时 25 英尺步行(T25FW)的变化之间的横断面和纵向相关性。

结果

在完整队列(r = 0.66,p <.001,n = 248)和进行性患者(r = 0.72,p <.001,n = 35)中,GNDS 和 EDSS 之间的横断面相关性最强,GNDS 和 T25FW 在进行性 MS 中相关性最强(r = 0.64,p <.001,n = 34)。纵向相关性较差,除了 GNDS 的腿部域的变化与进行性 MS 的 T25FW 变化之间的变化(r = 0.68,p <.001,n = 26)。在大多数情况下,EDSS 的临床显著恶化也导致 GNDS 和 MSIS 的临床显著恶化。

结论

PROM 与身体残疾结果密切相关,似乎适合检测进行性 MS 中下肢功能的变化。GNDS 与 EDSS 进展的一致性高于 MSIS 物理。

相似文献

1
The use of multi-domain patient reported outcome measures for detecting clinical disease progression in multiple sclerosis.多领域患者报告结局测量在多发性硬化症中检测临床疾病进展的应用。
Mult Scler Relat Disord. 2021 Oct;55:103165. doi: 10.1016/j.msard.2021.103165. Epub 2021 Jul 29.
2
Detecting clinically-relevant changes in progressive multiple sclerosis.检测进展性多发性硬化症的临床相关变化。
Mult Scler. 2015 Feb;21(2):171-9. doi: 10.1177/1352458514540969. Epub 2014 Jul 10.
3
Multiple Sclerosis Impact Scale (MSIS-29): relation to established measures of impairment and disability.多发性硬化症影响量表(MSIS - 29):与既定的损伤和残疾测量方法的关系
Mult Scler. 2004 Oct;10(5):569-74. doi: 10.1191/1352458504ms1078oa.
4
Clinical scales in progressive MS: predicting long-term disability.进展性多发性硬化症的临床量表:预测长期残疾。
Mult Scler. 2012 Mar;18(3):345-50. doi: 10.1177/1352458511419880. Epub 2011 Aug 25.
5
One year changes in disability in multiple sclerosis: neurological examination compared with patient self report.多发性硬化症患者残疾情况的一年变化:神经学检查与患者自我报告的比较
J Neurol Neurosurg Psychiatry. 2003 Apr;74(4):439-42. doi: 10.1136/jnnp.74.4.439.
6
Clinical impact of 20% worsening on Timed 25-foot Walk and 9-hole Peg Test in multiple sclerosis.多发性硬化症中25英尺定时步行试验和9孔插针试验恶化20%的临床影响。
Mult Scler. 2006 Oct;12(5):594-8. doi: 10.1177/1352458506070768.
7
The INTERMED: a screening instrument to identify multiple sclerosis patients in need of multidisciplinary treatment.INTERMED:一种用于识别需要多学科治疗的多发性硬化症患者的筛查工具。
J Neurol Neurosurg Psychiatry. 2003 Jan;74(1):20-4. doi: 10.1136/jnnp.74.1.20.
8
Multiple sclerosis impairment scale and brain MRI in secondary progressive multiple sclerosis.多发性硬化功能量表与继发进展型多发性硬化的脑 MRI。
Acta Neurol Scand. 2022 Mar;145(3):332-347. doi: 10.1111/ane.13554. Epub 2021 Nov 19.
9
Middle-range scores from the patient determined disease steps scale reflect varying levels of walking dysfunction in multiple sclerosis.从中程评分来看,患者确定疾病步骤量表反映了多发性硬化症患者在行走功能障碍方面存在不同程度的差异。
BMC Neurol. 2024 Oct 10;24(1):383. doi: 10.1186/s12883-024-03871-1.
10
Walking speed, rather than Expanded Disability Status Scale, relates to long-term patient-reported impact in progressive MS.在进展性多发性硬化症中,与长期患者报告的影响相关的是步行速度,而不是扩展残疾状况量表。
Mult Scler. 2013 Mar;19(3):326-33. doi: 10.1177/1352458512454346. Epub 2012 Aug 20.

引用本文的文献

1
Uncovering heterogeneous cognitive trajectories in relapsing-remitting multiple sclerosis: a longitudinal study.揭示复发缓解型多发性硬化症中的异质性认知轨迹:一项纵向研究。
Acta Neurol Belg. 2025 Apr;125(2):519-530. doi: 10.1007/s13760-025-02754-7. Epub 2025 Mar 15.
2
Patient-reported outcomes of quality of life before and after autologous hematopoietic stem cell transplantation for multiple sclerosis.多发性硬化症自体造血干细胞移植前后患者报告的生活质量结果。
Mult Scler. 2025 Apr;31(4):455-463. doi: 10.1177/13524585251315363. Epub 2025 Feb 17.
3
Understanding the Symptoms and Impacts Experienced by People with Relapsing-Remitting MS: A Qualitative Investigation Using Semi-Structured Interviews.
了解复发缓解型多发性硬化症患者所经历的症状及影响:一项采用半结构化访谈的定性研究
Neurol Ther. 2024 Apr;13(2):449-464. doi: 10.1007/s40120-024-00584-y. Epub 2024 Feb 12.
4
The MSIS-29 and SF-36 as outcomes in secondary progressive MS trials.多发性硬化症进展期临床试验中的 MSIS-29 和 SF-36 作为结局指标。
Mult Scler. 2022 Sep;28(10):1606-1619. doi: 10.1177/13524585221105465.